Literature DB >> 24070613

Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors.

Kalyani Mondal1, Karin Regnstrom, Winse Morishige, Robin Barbour, Gary Probst, Ying-Zi Xu, Dean R Artis, Nanhua Yao, Paul Beroza, Michael P Bova.   

Abstract

Alzheimer's disease (AD) is a devastating neurodegenerative disease affecting millions of people. β-Secretase-1 (BACE-1), an enzyme involved in the processing of the amyloid precursor protein (APP) to form Aβ, is a well validated target for AD. Herein, the authors characterize 10 randomly selected hydroxyethylamine (HEA) BACE-1 inhibitors in terms of their association and dissociation rate constants and thermodynamics of binding using surface plasmon resonance (SPR). Rate constants of association (ka) measured at 25 °C ranged from a low of 2.42×10(4) M(-1) s(-1) to the highest value of 8.3×10(5) M(-1) s(-1). Rate constants of dissociation (kd) ranged from 1.09×10(-4) s(-1) (corresponding to a residence time of close to three hours), to the fastest of 0.028 s(-1). Three compounds were selected for further thermodynamic analysis where it was shown that equilibrium binding was enthalpy driven while unfavorable entropy of binding was observed. Structural analysis revealed that upon ligand binding, the BACE-1flap folds down over the bound ligand causing an induced fit. The maximal difference between alpha carbon positions in the open and closed conformations of the flap was over 5 Å. Thus the negative entropy of binding determined using SPR analysis was consistent with an induced fit observed by structural analysis.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Hydroxyethylamine; Kinetics; Residence time; SPR; Thermodynamics; β-Secretase

Mesh:

Substances:

Year:  2013        PMID: 24070613     DOI: 10.1016/j.bbrc.2013.09.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.

Authors:  Z Yu; A P IJzerman; L H Heitman
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

2.  High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance.

Authors:  Phuong-Cac T Nguyen; Kenneth B Lewis; Ruth A Ettinger; Jason T Schuman; Jasper C Lin; John F Healey; Shannon L Meeks; Pete Lollar; Kathleen P Pratt
Journal:  Blood       Date:  2014-03-03       Impact factor: 22.113

3.  Oral effectiveness of PMIC4, a novel hydroxyethylpiperazine analogue, in Leishmania amazonensis.

Authors:  Mariela Ferreira de Vasconcelos; Edézio Ferreira da Cunha-Júnior; Valter Viana de Andrade-Neto; Larissa Moreira Siqueira; Cláudia Masini d'Avila-Levy; Marcele Moreth; Wilson Cunico; Marcus Vinícius Nora de Souza; Cláudia Regina Brandão Gomes; Eduardo Caio Torres-Santos
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-11-08       Impact factor: 4.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.